Jiyong Wu Selected Research

Squamous Cell Carcinoma of Head and Neck

1/2023

Veratricplatin inhibits the progression of hypopharyngeal squamous cell carcinoma FaDu cells in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiyong Wu Research Topics

Disease

3	Neoplasms (Cancer) 07/2023 - 03/2022
1	Rhabdomyolysis 03/2024
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2024
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2023
1	Lymphoid Leukemia 12/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Anemia 01/2023
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2023
1	Neoplasm Metastasis (Metastasis) 03/2022
1	Gram-Negative Bacterial Infections 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Soft Tissue Infections 01/2022
1	Hemorrhage 01/2022
1	Mycoses (Diseases, Fungus) 01/2022

Drug/Important Bio-Agent (IBA)

2	PlatinumIBA 01/2024 - 01/2022
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 03/2024
1	Monoclonal AntibodiesIBA 01/2024
1	Programmed Cell Death 1 ReceptorIBA 01/2024
1	pembrolizumabIBA 01/2024
1	Agammaglobulinaemia Tyrosine KinaseIBA 12/2023
1	Bendamustine Hydrochloride FDA Link 12/2023
1	Rituximab (Mabthera)FDA Link 12/2023
1	zanubrutinibIBA 12/2023
1	TubulinIBA 07/2023
1	veratric acidIBA 01/2023
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2023
1	IronIBA 01/2023
1	Histone Deacetylase InhibitorsIBA 01/2023
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2022
1	Cisplatin (Platino)FDA LinkGeneric 03/2022
1	bendazacIBA 03/2022
1	ProdrugsIBA 03/2022
1	Tigecycline (Tygacil)FDA Link 01/2022
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	niraparibIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	olaparibIBA 01/2022
1	Isocitrate LyaseIBA 01/2022
1	BilirubinIBA 01/2022

Therapy/Procedure

5	Therapeutics 07/2023 - 01/2022
1	Drug Therapy (Chemotherapy) 01/2024
1	Duration of Therapy 01/2022